Vascular access for cancer chemotherapy

Eleven bovine heterografts were utilized in the repetitive administration of chemotherapy in 10 patients with insufficient vascular access. Six grafts remained patent until the time of death and five grafts clotted from 71 to 1110 days postoperatively. Three patients are alive and well. All grafts w...

Full description

Saved in:
Bibliographic Details
Published in:Cancer 1979-05, Vol.43 (5), p.1934-1936
Main Authors: Lempert, Neil, MacDowell, Richard T., Karmody, Allastair, Knight, Edward, Cunningham, Thomas J., Sponzo, Robert W., Horton, John, Ruckdeschel, John C.
Format: Article
Language:English
Subjects:
Animals
Antineoplastic Agents - administration & dosage
Arteries - transplantation
Arteriovenous Shunt, Surgical - methods
Brachial Artery
Cattle
Humans
Transplantation, Heterologous
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Eleven bovine heterografts were utilized in the repetitive administration of chemotherapy in 10 patients with insufficient vascular access. Six grafts remained patent until the time of death and five grafts clotted from 71 to 1110 days postoperatively. Three patients are alive and well. All grafts were initially patent and no wound infections resulted. The bovine heterograft appears to be a useful adjunct for securing vascular access for patients requiring cancer chemotherapy.
ISSN:0008-543X
1097-0142
DOI:10.1002/1097-0142(197905)43:5<1934::AID-CNCR2820430553>3.0.CO;2-4